144 related articles for article (PubMed ID: 30368216)
1. Expression, Clinical Significance, and Functional Prediction of MNX1 in Breast Cancer.
Tian T; Wang M; Zhu Y; Zhu W; Yang T; Li H; Lin S; Dai C; Deng Y; Song D; Li N; Zhai Z; Dai ZJ
Mol Ther Nucleic Acids; 2018 Dec; 13():399-406. PubMed ID: 30368216
[TBL] [Abstract][Full Text] [Related]
2. MNX1-AS1 is a novel biomarker for predicting clinical progression and poor prognosis in lung adenocarcinoma.
Yang R; Wang L; Han M
J Cell Biochem; 2019 May; 120(5):7222-7228. PubMed ID: 30506837
[TBL] [Abstract][Full Text] [Related]
3. Upregulated expression of MNX1-AS1 long noncoding RNA predicts poor prognosis in gastric cancer.
Zhang W; Huang L; Lu X; Wang K; Ning X; Liu Z
Bosn J Basic Med Sci; 2019 May; 19(2):164-171. PubMed ID: 30821221
[TBL] [Abstract][Full Text] [Related]
4. MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer.
Chi W; Xiu B; Xiong M; Wang X; Li P; Zhang Q; Hou J; Sang Y; Zhou X; Chen M; Zheng S; Zhang L; Xue J; Chi Y; Wu J
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203393
[TBL] [Abstract][Full Text] [Related]
5. Macrophages Promote Subtype Conversion and Endocrine Resistance in Breast Cancer.
Zhang X; Yang F; Huang Z; Liu X; Xia G; Huang J; Yang Y; Li J; Huang J; Liu Y; Zhou T; Qi W; Gao G; Yang X
Cancers (Basel); 2024 Feb; 16(3):. PubMed ID: 38339428
[TBL] [Abstract][Full Text] [Related]
6. Motor Neuron and Pancreas Homeobox 1 (MNX1) Is Involved in Promoting Squamous Cervical Cancer Proliferation via Regulating Cyclin E.
Xiao L; Hong L; Zheng W
Med Sci Monit; 2019 Aug; 25():6304-6312. PubMed ID: 31436258
[TBL] [Abstract][Full Text] [Related]
7. MNX1 Promotes Malignant Progression of Cervical Cancer via Repressing the Transcription of p21
Zhu B; Wu Y; Luo J; Zhang Q; Huang J; Li Q; Xu L; Lu E; Ren B
Front Oncol; 2020; 10():1307. PubMed ID: 32850410
[TBL] [Abstract][Full Text] [Related]
8. Motor neuron and pancreas homeobox 1/HLXB9 promotes sustained proliferation in bladder cancer by upregulating CCNE1/2.
Chen M; Wu R; Li G; Liu C; Tan L; Xiao K; Ye Y; Qin Z
J Exp Clin Cancer Res; 2018 Jul; 37(1):154. PubMed ID: 30012177
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA MNX1-AS1 Promotes Progression of Triple Negative Breast Cancer by Enhancing Phosphorylation of Stat3.
Li J; Li Q; Li D; Shen Z; Zhang K; Bi Z; Li Y
Front Oncol; 2020; 10():1108. PubMed ID: 32754442
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of LncRNA MNX1-AS1 in non-small cell lung cancer.
Liu G; Guo X; Zhang Y; Liu Y; Li D; Tang G; Cui S
Onco Targets Ther; 2019; 12():3129-3138. PubMed ID: 31118668
[No Abstract] [Full Text] [Related]
11. Comparisons of p53, KI67 and BRCA1 expressions in patients with different molecular subtypes of breast cancer and their relationships with pathology and prognosis.
Li Y; Zhang X; Qiu J; Pang T; Huang L; Zeng Q
J BUON; 2019; 24(6):2361-2368. PubMed ID: 31983107
[TBL] [Abstract][Full Text] [Related]
12. Breast Cancer Subtypes Based on Hypoxia-Related Gene Sets Identify Potential Therapeutic Agents.
Xiong Z; Huang W; Zhong W; Fu J; Feng J; Wang X; Ling F
Front Mol Biosci; 2022; 9():900005. PubMed ID: 35847977
[No Abstract] [Full Text] [Related]
13. Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer.
Li AH; Zhang HH
Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5618-5623. PubMed ID: 29271994
[TBL] [Abstract][Full Text] [Related]
14. Ki67 and lymphocytes in the pretherapeutic core biopsy of primary invasive breast cancer: positive markers of therapy response prediction and superior survival.
Schlotter CM; Tietze L; Vogt U; Heinsen CV; Hahn A
Horm Mol Biol Clin Investig; 2017 Sep; 32(2):. PubMed ID: 28937963
[TBL] [Abstract][Full Text] [Related]
15. MNX1 reduces sensitivity to anoikis by activating TrkB in human glioma cells.
Jiang L; Chen S; Zhao D; Yan J; Chen J; Yang C; Zheng G
Mol Med Rep; 2018 Sep; 18(3):3271-3279. PubMed ID: 30066929
[TBL] [Abstract][Full Text] [Related]
16. Additional Nodal Disease Prediction in Breast Cancer with Sentinel Lymph Node Metastasis Based on Clinicopathological Features.
Orsaria P; Caredda E; Genova F; Materazzo M; Capuano I; Vanni G; Granai AV; DE Majo A; Portarena I; Sileri P; Petrella G; Palombi L; Buonomo OC
Anticancer Res; 2018 Apr; 38(4):2109-2117. PubMed ID: 29599329
[TBL] [Abstract][Full Text] [Related]
17. LncRNA MNX1-AS1 promotes progression of esophageal squamous cell carcinoma by regulating miR-34a/SIRT1 axis.
Chu J; Li H; Xing Y; Jia J; Sheng J; Yang L; Sun K; Qu Y; Zhang Y; Yin H; Wan J; He F
Biomed Pharmacother; 2019 Aug; 116():109029. PubMed ID: 31170665
[TBL] [Abstract][Full Text] [Related]
18. Increased Expression of microRNA-141-3p Improves Necrotizing Enterocolitis of Neonates Through Targeting MNX1.
Chen H; Zeng L; Zheng W; Li X; Lin B
Front Pediatr; 2020; 8():385. PubMed ID: 32850524
[No Abstract] [Full Text] [Related]
19. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
20. Role of PAX2 in breast cancer verified by bioinformatics analysis and
Yang S; Gao W; Wang H; Zhang X; Mi Y; Ding Y; Geng C; Zhang J; Cheng M; Li S
Ann Transl Med; 2023 Jan; 11(2):58. PubMed ID: 36819548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
